Abstract
Herpes simplex viruses (HSV) are human pathogens responsible for a variety of diseases, including localized mucocutaneous lesions, encephalitis, and disseminated diseases. HSV infection leads to rapid induction of innate immune responses. A critical part of this host response is the type I IFN system including the induction of type I IFNs, IFN-mediated signaling and amplification of IFN response. This provides the host with immediate countermeasure during acute infection to limit initial viral replication and to facilitate an appropriate adaptive immune response. However, HSV has devised multiple strategies to evade and interfere with innate immunity. This review will focus on the induction of type I IFN response by HSV during acute infection and current knowledge of mechanisms by which HSV interferes with this induction process.
Similar content being viewed by others
References
Alexopoulou L, Holt A C, Medzhitov R, et al. 2001. Recognition of double-stranded RNA and activation of NF-[kappa]B by Toll-like receptor 3. Nature, 413(6857): 732.
Ankel H, Westra D F, Welling-Wester S, et al. 1998. Induction of Interferon-[alpha] by Glycoprotein D of Herpes Simplex Virus: A Possible Role of Chemokine Receptors. Virology, 251(2): 317.
Aravalli R, Peterson P, Lokensgard J. 2007. Toll-like Receptors in Defense and Damage of the Central Nervous System. J Neuroimmune Pharmacol, 2(4): 297.
Au W, Moore P A, LaFleur D W, et al. 1998. Characterization of the Interferon Regulatory Factor-7 and Its Potential Role in the Transcription Activation of Interferon A Genes. J Biol Chem, 273(44): 29210–29217.
Au W, Moore P A, Lowther W, et al. 1995. Identification of a Member of the Interferon Regulatory Factor Family that Binds to the Interferon-Stimulated Response Element and Activates Expression of Interferon-Induced Genes. Proc Natl Acad Scie USA, 92(25): 11657–11661.
Bosnjak L, Jones C A, Abendroth A, et al. 2005. Dendritic Cell Biology in Herpesvirus Infections. Viral Immunol, 18(3): 419–433.
Casrouge A, Zhang S Y, Eidenschenk C, et al. 2006. Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency. Science, 314(5797): 308–312.
Cassady K A, Gross M, Roizman B. 1998. The Second-Site Mutation in the Herpes Simplex Virus Recombinants Lacking the gamma 134.5 Genes Precludes Shutoff of Protein Synthesis by Blocking the Phosphorylation of eIF-2alpha. J Virol, 72(9): 7005–7011.
Cassady K A, Gross M, Roizman B. 1998. The Herpes Simplex Virus Us11 Protein Effectively Compensates for the γ134.5 Gene if Present before Activation of Protein Kinase R by Precluding Its Phosphorylation and That of the alpha subunit of Eukaryotic Translation Initiation Factor 2. J Virol, 72(11): 8620–8626.
Cerveny M, Hessefort S, Yang K, et al. 2003. Amino acid substitutions in the effector domain of the g134.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-a. Virology, 307(2): 290.
Chee A V, Roizman B. 2004. Herpes Simplex Virus 1 Gene Products Occlude the Interferon Signaling Pathway at Multiple Sites. J Virol, 78(8): 4185–4196.
Cheng G, Brett M E, He B. 2001. Val193 and Phe195 of the γ134.5 Protein of Herpes Simplex Virus 1 Are Required for Viral Resistance to Interferon-α/β. Virology, 290(1): 115
Cheng G, Gross M, Brett M E, et al. 2001. AlaArg Motif in the Carboxyl Terminus of the γ134.5 Protein of Herpes Simplex Virus Type 1 Is Required for the Formation of a High-Molecular-Weight Complex That Dephosphorylates eIF-2a. J Virol, 75(8): 3666–3674.
Cheng G, Yang K, He B. 2003. Dephosphorylation of eIF-2a Mediated by the g134.5 Protein of Herpes Simplex Virus Type 1 Is Required for Viral Response to Interferon but Is Not Sufficient for Efficient Viral Replication. J Virol, 77(18): 10154–10161.
Cheng G, Zhong J, Chung J, et al. 2007. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Scie USA, 104(21): 9035–9040.
Collins S E, Noyce R S, Mossman K L. 2004. Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication. J Virol, 78(4): 1706–1717.
Diebold S S, Kaisho T, Hemmi H, et al. 2004. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA. Science, 303(5663): 1529–1531.
Duerst R J, Morrison L A. 2004. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology, 322(1): 158.
Eidson K M, Hobbs W E, Manning B J, et al. 2002. Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection. J Virol, 76(5): 2180–2191.
Elain G, Romero P, Segal D, et al. 2007. TLR3 Deficiency in Patients with Herpes Simplex Encephalitis. Science, 317(5844): 1522–1527.
Fitzgerald K A, McWhirter S M, Faia K L, et al. 2003. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol, 4(5): 491.
Garcia-Sastre A, Biron C A. 2006. Type 1 Interferons and the Virus-Host Relationship: A Lesson in Detente. Science, 312(5775):879–882.
Garcia M A, Meurs E F, Esteban M. 2007. The dsRNA protein kinase PKR: Virus and cell control. Biochimie, 89(6–7): 799.
Gitlin L, Barchet W, Gilfillan S, et al. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Scie USA, 103(22): 8459–8464.
Guo J, Peters K L, Sen G C. 2000. Induction of the Human Protein P56 by Interferon, Double-Stranded RNA, or Virus Infection. Virology, 267(2): 209.
Hacker H, Redecke V, Blagoev B, et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature, 439(7073): 204.
He B, Chou J, Brandimarti R, et al. 1997. Suppression of the phenotype of γ134.5− herpes simplex virus 1: failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the α 47 gene. J Virol, 71(8): 6049–6054.
He B, Gross M, Roizman B. 1997. The γ134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. PNAS, 94(3): 843–848.
Heil F, Hemmi H, Hochrein H, et al. 2004. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8. Science, 303(5663): 1526–1529.
Hemmi H, Takeuchi O, Kawai T, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature, 408(6813):740.
Herbst-Kralovetz M M, Pyles R B. 2006. Toll-like Receptors, Innate Immunity and HSV Pathogenesis. Herpes, 13(2): 37–41.
Hochrein H, Schlatter B, O’Keeffe M, et al. 2004. Herpes simplex virus type-1 induces IFN-{alpha} production via Toll-like receptor 9-dependent and-independent pathways. Proc Natl Acad Scie USA, 101(31): 11416–11421.
Hornung V, Ellegast J, Kim S, et al. 2006. 5′-Triphosphate RNA Is the Ligand for RIG-I. Science, 314(5801): 994–997.
Ishii K J, Akira S. 2006. Innate immune recognition of, and regulation by, DNA. Trends Immunol, 27(11): 525.
Ishii K J, Coban C, Kato H, et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol, 7(1): 40.
Ishii K J, Kawagoe T, Koyama S, et al. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature, 451(7179): 725.
Jacquemont B, Roizman B. 1975. RNA synthesis in cells infected with herpes simplex virus. X. Properties of viral symmetric transcripts and of double-stranded RNA prepared from them. J Virol, 15(4): 707–713.
Jiang Z, Mak T W, Sen G, et al. 2004. Toll-like receptor 3-mediated activation of NF-{kappa}B and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-{beta}. Proc Natl Acad Scie USA, 101(10): 3533–3538.
Johnson K E, Song B, Knipe D M. 2008. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology, 374(2): 487.
Kato H, Takeuchi O, Sato S, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 441(7089): 101.
Kawai T, Takahashi K, Sato S, et al. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol, 6(10): 981.
Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat Immunol, 7(2): 131.
Kim J C, Lee S Y, Kim S Y, et al. 2008. HSV-1 ICP27 suppresses NF-[kappa]B activity by stabilizing I[kappa]B [alpha]. FEBS Letters, 582(16): 2371.
Konat G W, Kielian T, Marriott I. 2006. The role of Toll-like receptors in CNS response to microbial challenge. J Neurochem, 99(1): 1–12.
Korom M, Wylie K M, Morrison L A. 2008. Selective Ablation of Virion Host Shutoff Protein RNase Activity Attenuates Herpes Simplex Virus 2 in Mice. J Virol, 82(7): 3642–3653.
Krug A, Luker G D, Barchet W, et al. 2004. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood, 103(4): 1433–1437.
Ku C L, von Bernuth H, Picard C, et al. 2007. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity. J Exp Med, 204(10): 2407–2422.
Kumar-Sinha C, Varambally S, Sreekumar A, et al. 2002. Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways. J Biol Chem, 277(1): 575–585.
Kumar H, Zheng M, Atherton S S, et al. 2006. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology, 117(2): 167–176.
Kurt-Jones E A, Chan M, Zhou S, et al. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Scie USA, 101(5): 1315–1320.
Lebon P. 1985. Inhibition of Herpes Simplex Virus Type 1-induced Interferon Synthesis by Monoclonal Antibodies against Viral Glycoprotein D and by Lysosomotropic Drugs. J Gen Virol, 66(12): 2781–2786.
Leib D A, Harrison T E, Laslo K M, et al. 1999. Interferons Regulate the Phenotype of Wild-type and Mutant Herpes Simplex Viruses In Vivo. J Exp Med, 189(4): 663–672.
Lin R, Noyce R S, Collins S E, et al. 2004. The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3-and IRF7-Mediated Activation of Interferon-Stimulated Genes. J Virol, 78(4): 1675–1684.
Lund J, Sato A, Akira S, et al. 2003. Toll-like Receptor 9-mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells. J Exp Med, 198(3): 513–520.
Malmgaard L, Paludan S. R. 2003. Interferon (IFN)-{alpha}/{beta}, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-{gamma} during infection with herpes simplex virus type 2. J Gen Virol, 84(9): 2497–2500.
Malmgaard L, Melchjorsen J, Bowie A G, et al. 2004. Viral Activation of Macrophages through TLR-Dependent and-Independent Pathways. J Immunol, 173(11): 6890–6898.
Medzhitov R, Preston-Hurlburt P, Kopp E, et al. 1998. MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling Pathways. Mol Cell, 2(2): 253–258.
Melchjorsen J, Siren J, Julkunen I, et al. 2006. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-{kappa}B and IRF-3. J Gen Virol, 87(5): 1099–1108.
Melroe G T, DeLuca N A, Knipe D M. 2004. Herpes Simplex Virus 1 Has Multiple Mechanisms for Blocking Virus-Induced Interferon Production. J Virol, 78(16): 8411–8420.
Melroe G T, Silva L, Schaffer P A, et al. 2007. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-[beta] induction. Virology, 360(2): 305.
Mercurio F, Zhu H, Murray B W, et al. 1997. IKK-1 and IKK-2: Cytokine-Activated I{kappa}B Kinases Essential for NF-B Activation. Science, 278(5339): 860–866.
Meylan E, Curran J, Hofmann K, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 437(7062): 1167.
Mohr I, Sternberg D, Ward S, et al. 2001. A Herpes Simplex Virus Type 1 γ134.5 Second-Site Suppressor Mutant That Exhibits Enhanced Growth in Cultured Glioblastoma Cells Is Severely Attenuated in Animals. J Virol, 75(11): 5189–5196.
Mohrl I, Gluzman Y. 1996. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J, 15(17): 4759–4766.
Mossman K L, Saffran H A, Smiley J R. 2000. Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon. J Virol, 74(4): 2052–2056.
Mossman K L, Macgregor P F, Rozmus J J, et al. 2001. Herpes Simplex Virus Triggers and Then Disarms a Host Antiviral Response. J Virol, 75(2): 750–758.
Mossman K L, Ashkar A A. 2005. Herpesviruses and the Innate Immune Response. Viral Immunol, 18(2): 267–281.
Murphy J A, Duerst R J, Smith T J, et al. 2003. Herpes Simplex Virus Type 2 Virion Host Shutoff Protein Regulates Alpha/Beta Interferon but Not Adaptive Immune Responses during Primary Infection In Vivo. J Virol, 77(17): 9337–9345.
Narita M, Ando Y, Soushi S, et al. 1998. The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon. J Gen Virol, 79(3): 565–572.
Nicholl M J, Robinson L H, Preston C M. 2000. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol, 81(9): 2215–2218.
Ninomiya-Tsuji J, Kishimoto K, Hiyama A, et al. 1999. The kinase TAK1 can activate the NIK-I[kappa]B as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature, 398(6724): 252.
Noyce R S, Collins S E, Mossman K L. 2006. Identification of a Novel Pathway Essential for the Immediate-Early, Interferon-Independent Antiviral Response to Enveloped Virions. J Virol, 80(1): 226–235.
Oganesyan G, Saha S K, Guo B, et al. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature, 439(7073): 208.
Okabe Y, Kawane K, Akira S, et al. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med, 202(10): 1333–1339.
Oshiumi H, Matsumoto M, Funami K, et al. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-[beta] induction. Nat Immunol, 4(2): 161.
Overton H, McMillan D, Hope L, et al. 1994. Production of Host Shutoff-Defective Mutants of Herpes Simplex Virus Type 1 by Inactivation of the UL13 Gene. Virology, 202(1): 97.
Paladino P, Cummings D T, Noyce R S, et al. 2006. The IFN-Independent Response to Virus Particle Entry Provides a First Line of Antiviral Defense That Is Independent of TLRs and Retinoic Acid-Inducible Gene I. J Immunol, 177(11): 8008–8016.
Pasieka T J, Baas T, Carter V S, et al. 2006. Functional Genomic Analysis of Herpes Simplex Virus Type 1 Counteraction of the Host Innate Response. J Virol, 80(15): 7600–7612.
Pasieka T J, Lu B, Crosby S D, et al. 2008. Herpes Simplex Virus Virion Host Shutoff Attenuates Establishment of the Antiviral State. J Virol, 82(11): 5527–5535.
Pedersen E B, Haahr S, Mogensen S C. 1983. X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production. Infect Immun, 42(2): 740–746.
Perry A K, Chen G, Zheng D, et al. 2005. The host type I interferon response to viral and bacterial infections. Cell Res, 15(6): 407.
Pichlmair A, Schulz O, Tan C P, et al. 2006. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5′-Phosphates. Science, 314(5801): 997–1001.
Platanias L C. 2005. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol, 5(5):375.
Preston C M, Harman A N, Nicholl M J. 2001. Activation of Interferon Response Factor-3 in Human Cells Infected with Herpes Simplex Virus Type 1 or Human Cytomegalovirus. J Virol, 75(19): 8909–8916.
Rasmussen S B, Sorensen L N, Malmgaard L, et al. 2007. Type I Interferon Production during Herpes Simplex Virus Infection Is Controlled by Cell-Type-Specific Viral Recognition through Toll-Like Receptor 9, the Mitochondrial Antiviral Signaling Protein Pathway, and Novel Recognition Systems. J Virol, 81(24): 13315–13324.
Reske A, Pollara G, Krummenacher C, et al. 2008. Glycoprotein-Dependent and TLR2-Independent Innate Immune Recognition of Herpes Simplex Virus-1 by Dendritic Cells. J Immunol, 180(11): 7525–7536.
Roizman B. 1999. HSV gene functions: what have we learned that could be generally applicable to its near and distant cousins? Acta Virol, 43(2–3): 75–80.
Roizman B, Knipe D M. 2001. Herpes simplex viruses and their replication. In: Fields Virology (Knipe D M, Howley P, Griffin D, et al ed.), 4th ed, vol. 2. Lippincott Williams & Wilkins, p 2399–2459.
Rong Q, Alexander T S, Koski G K, et al. 2003. Multiple mechanisms for HSV-1 induction of interferon α production by peripheral blood mononuclear cells. Arch Virol, 148(2): 329.
Sato A, Linehan M M, Iwasaki A. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Scie USA, 103(46): 17343–17348.
Sato M, Suemori H, Hata N, et al. 2000. Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-[alpha]/[beta] Gene Induction. Immunity, 13(4): 539.
Sato M, Taniguchi T, Tanaka N. 2001. The interferon system and interferon regulatory factor transcription factors-studies from gene knockout mice. Cytokine & Growth Factor Rev, 12(2–3): 133.
Sato S, Sugiyama M, Yamamoto M, et al. 2003. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-{beta} (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-{kappa}B and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling. J Immunol, 171(8): 4304–4310.
Seth R B, Sun L, Ea C K, et al. 2005. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3. Cell, 122(5): 669–682.
Sharma S, tenOever B R, Grandvaux N, et al. 2003. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway. Science, 300(5622): 1148–1151.
Shimada T, Kawai T, Takeda K, et al. 1999. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to I{kappa}B kinases. Int Immunol, 11(8): 1357–1362.
Shirota H, Ishii K J, Takakuwa H, et al. 2006. Contribution of interferon-β to the immune activation induced by double-stranded DNA. Immunology, 118(3): 302–310.
Smiley J R. 2004. Herpes Simplex Virus Virion Host Shutoff Protein: Immune Evasion Mediated by a Viral RNase? J Virol, 78(3): 1063–1068.
Stetson D B, Medzhitov R. 2006. Type I Interferons in Host Defense. Immunity, 25(3): 373–381.
Stetson D B, Medzhitov R. 2006. Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response. Immunity, 24(1): 93–103.
Su Y H, Oakes J E, Lausch R N. 1993. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon {alpha}/beta. J Gen Virol, 74(11): 2325–2332.
Sun Q, Sun L, Liu H H, et al. 2006. The Specific and Essential Role of MAVS in Antiviral Innate Immune Responses. Immunity, 24(5): 633.
Suzutani T, Nagamine M, Shibaki T, et al. 2000. The role of the UL41 gene of herpes simplex virus type 1 invasion of non-specific host defence mechanisms during primary infection. J Gen Virol, 81(7): 1763–1771.
Takaoka A, Wang Z, Choi M K, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 448(7152): 501.
Takeda K, Akira S. 2004. TLR signaling pathways Semin Immunol, 16(1): 3–9.
Wang Z, Choi M K, Ban T, et al. 2008. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Scie USA, 105(14): 5477–5482.
Wathelet M G, Lin C H, Parekh B S, et al. 1998. Virus Infection Induces the Assembly of Coordinately Activated Transcription Factors on the IFN-[beta] Enhancer In Vivo. Mol Cell, 1(4): 507.
Weber F, Wagner V, Rasmussen S B, et al. 2006. Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses. J Virol, 80(10): 5059–5064.
Xu L G, Wang Z, Han K J, et al. 2005. VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling. Mol Cell, 119(6): 727–740.
Yamamoto M, Sato S, Mori K, et al. 2002. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-{beta} Promoter in the Toll-Like Receptor Signaling. J Immunol, 169(12): 6668–6672.
Yang H, Lin C H, Ma G, et al. 2002. Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur J Biochem, 269(24): 6142–6151.
Yang K, Puel A, Zhang S, et al. 2005. Human TLR-7-,-8-, and-9-mediated induction of IFN-[alpha]/[beta] and-[lambda] is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity, 23(5): 465.
Yoneyama M, Suhara W, Fukuhara Y, et al. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J, 17(4): 1087–1095.
Yoneyama M, Kikuchi M, Natsukawa T, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol, 5(7): 730.
Zandi E, Rothwarf D M, Delhase M, et al. 1997. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation. cell, 91(2): 243–252.
Zawatzky R, Kirchner H, DeMaeyer-Guignard J, et al. 1982. An X-linked Locus Influences the Amount of Circulating Interferon Induced in the Mouse by Herpes Simplex Virus Type 1. J Gen Virol, 63(2): 325–332.
Zhang S Y, Jouanguy E, Sancho-Shimizu V, et al. 2007. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev, 220(1): 225–236.
Zheng M, Klinman D M, Gierynska M, et al. 2002. DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Scie USA, 99(13): 8944–8949.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, Y., Verpooten, D. & He, B. Herpes simplex viruses and induction of interferon responses. Virol. Sin. 23, 416–428 (2008). https://doi.org/10.1007/s12250-008-2999-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-008-2999-7